The analyst's commentary reflects careful consideration of Haleon's latest guidance and market conditions, particularly the ...

Haleon PLC HLN shares dropped 1.63% to £3.67 Tuesday, on what proved to be an all-around favorable trading session for the ...

Haleon's global business lead for the Pain Portfolio & Systemics shares key consumer health trends reshaping the healthcare ...

Jefferies reiterated its Buy rating on Haleon PLC (HLN:LN) (NYSE: HLN), maintaining a price target of GBP4.50. Currently ...

On Jan 15, Pfizer Inc. ( PFE, Financial) announced to sale of about 700 million ordinary shares of Haleon plc through a ...

Shares of Haleon PLC HLN inched up 0.03% to £3.73 Monday, on what proved to be an all-around favorable trading session for ...

The sale decreases Pfizer’s shareholding in the consumer-healthcare business to 7.3% of its issued share capital, down from ...

She was previously the supplier's head of commercial excellence for Europe, Middle East, Africa & Latin America ...

In a report released today, Iain Simpson from Barclays maintained a Buy rating on Haleon PLC (HLN – Research Report), with a price target of ...

Pfizer Inc. sold about 700 million shares in Haleon Plc, further paring its stake in the maker of Sensodyne toothpaste.Most ...

LAHORE: Haleon, multinational company is establishing a Pain Management Institute in Lahore to carry out research ...

Haleon, a global leader in consumer health, has taken a revolutionizing step for pain management by launching the Haleon Pain ...